Purchase Order 75D30126P21135
Award Date 7/4/26
Potential Completion Date 8/31/28
Potential Value $86K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $121,493 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for instrument service. The contract has no set-aside designation. BD is a global medical technology company that specializes in providing instruments, reagents, and services to support biomedical research and clinical applications, particularly in the areas of flow cytometry, cell imaging, and genomics. BD has extensive experience providing...
- This federal contract award is for the purchase of a BD FACSYMPHONY A3 Cell Analyzer by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) in Pittsburgh. The prime contractor is Becton, Dickinson and Company (BD), a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics technologies. The contract is a firm fixed-price...
- This is a firm fixed price purchase order awarded to Becton, Dickinson and Company (BD) by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) for maintenance support services. The contract, which does not have a set-aside designation, has a potential value of $110,986.32 and a period of performance ending on September 20, 2019. BD, a global medical technology company, has extensive experience providing equipment, reagents, and services to support...
- The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a definitive contract valued at approximately $1.45 million to Becton, Dickinson and Company, doing business as BD, for real-time access to inpatient clinical, laboratory, medication, and outcome data. The firm fixed price contract runs from September 2020 through September 2023 and will be performed in San Diego, California. BD will deliver data integration and analytics services to...
- The Centers for Disease Control and Prevention (CDC) awarded a $38,093 purchase order to Becton, Dickinson and Company for antibodies and reagents. Becton, Dickinson and Company, doing business as BD, will provide the requested bioscience products from its Franklin Lakes, New Jersey location to support CDC programs. No additional details were provided on the original solicitation or use of the antibodies and reagents. The single award was made on a firm-fixed-price basis with performance...
- This federal contract award is for Becton, Dickinson And Company (BD), a manufacturer of medical devices, instruments, reagents, and related products. The contract, valued at $428,903.24, was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh and does not have a set-aside designation. The contract is a delivery order contract of the type Indefinite Delivery/Indefinite Quantity (IDIQ), which allows the government to place orders for...
- This is a $19,491.05 firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD) for BD CSAMPLER PLUS products. The contract has an ultimate completion date of October 30, 2024 and was awarded on September 30, 2024. No set-aside designation was used. BD is a global medical technology company that provides instruments, reagents, and services to support biomedical research and clinical applications, including flow cytometry,...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Becton, Dickinson and Company (BD), a manufacturer of medical devices and supplies. The contract has a ceiling value of $194,940.24 and an ultimate completion date of September 20, 2024. The contract is not set aside for any small business designation. BD is a major manufacturer and supplier of medical equipment and consumables, including needles, syringes, intravenous catheters,...
- The U.S. Centers for Disease Control and Prevention (CDC) in Pittsburgh has awarded a $49,032 firm-fixed-price purchase order to Becton, Dickinson and Company (BD) for the BD Accuri C6+ System. This award, which has no set-aside designation, will support the agency's biomedical research and clinical programs. BD, a global medical technology manufacturer, has extensive experience providing specialized equipment and supplies, including flow cytometers and associated reagents, to various federal...
- This $110,986.32 firm fixed-price purchase order contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Becton, Dickinson And Company (BD), a global medical technology company, to provide laboratory instruments. The contract does not have a set-aside designation. BD, through its BD Biosciences division, is a major supplier of products and services for laboratory and biomedical research applications, including flow cytometers, cell...
CDC Pittsburgh awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) valued at $86,150.40 on July 4, 2026, with performance completion by August 31, 2028. Work is performed in Atlanta, Georgia. The order is firm fixed price with no small business set-aside. The specific scope of supplies or services is not detailed in the award documentation.
Generated 7/3/26, 10:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.6k | 7/1/26 |